Chabot GG et al. |
Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitro. |
1989 |
Cancer Chemother. Pharmacol. |
pmid:2758556
|
Damia G et al. |
Dose-dependent pharmacokinetics of flavone acetic acid in mice. |
1988 |
Cancer Chemother. Pharmacol. |
pmid:3396145
|
Ullmannova V and Popescu NC |
Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines. |
2007 |
Cancer Detect. Prev. |
pmid:17418982
|
Schumacher M et al. |
Potential role of P-gp for flavone-induced diminished apoptosis and increased adenoma size in the small intestine of APC(min/+) mice. |
2011 |
Cancer Invest. |
pmid:21649465
|
Po LS et al. |
Baicalein and genistein display differential actions on estrogen receptor (ER) transactivation and apoptosis in MCF-7 cells. |
2002 |
Cancer Lett. |
pmid:12359348
|
Cai H et al. |
Flavones as colorectal cancer chemopreventive agents--phenol-o-methylation enhances efficacy. |
2009 |
Cancer Prev Res (Phila) |
pmid:19638489
|
Oyama T et al. |
Dietary tricin suppresses inflammation-related colon carcinogenesis in male Crj: CD-1 mice. |
2009 |
Cancer Prev Res (Phila) |
pmid:19934339
|
Kanwar JR et al. |
Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci. |
2001 |
Cancer Res. |
pmid:11280751
|
Ching LM et al. |
Induction of tumor necrosis factor-alpha messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488). |
1994 |
Cancer Res. |
pmid:8313372
|
Rossi M et al. |
Molecular structures of 5,6- and 7,8-benzoflavones, inhibitors of aryl hydrocarbon hydroxylase. |
1980 |
Cancer Res. |
pmid:7388828
|
Shukla S et al. |
Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. |
2007 |
Cancer Res. |
pmid:17638904
|
Cummings J et al. |
Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and mice. |
1989 |
Cancer Res. |
pmid:2731178
|
Relling MV et al. |
Anticancer drugs as inhibitors of two polymorphic cytochrome P450 enzymes, debrisoquin and mephenytoin hydroxylase, in human liver microsomes. |
1989 |
Cancer Res. |
pmid:2908853
|
Wenzel U et al. |
Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. |
2000 |
Cancer Res. |
pmid:10919656
|
Weiss RB et al. |
Phase I and clinical pharmacology study of intravenous flavone acetic acid (NSC 347512). |
1988 |
Cancer Res. |
pmid:3167843
|
Kerr DJ et al. |
Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester). |
1986 |
Cancer Res. |
pmid:3698028
|
Evelhoch JL et al. |
Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy. |
1988 |
Cancer Res. |
pmid:3409216
|
Bissery MC et al. |
Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivo. |
1988 |
Cancer Res. |
pmid:3422592
|
Ahmed-Belkacem A et al. |
Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2. |
2005 |
Cancer Res. |
pmid:15930306
|
Kerr DJ et al. |
Phase I and pharmacokinetic study of flavone acetic acid. |
1987 |
Cancer Res. |
pmid:3677106
|